SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021038
Filing Date
2020-11-12
Accepted
2020-11-12 09:15:41
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 470058
2 ex10-2.htm EX-10.2 27958
3 ex31-1.htm EX-31.1 10662
4 ex31-2.htm EX-31.2 10606
5 ex32-1.htm EX-32.1 4542
  Complete submission text file 0001493152-20-021038.txt   2900852

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pulm-20200930.xml EX-101.INS 472395
7 XBRL SCHEMA FILE pulm-20200930.xsd EX-101.SCH 40337
8 XBRL CALCULATION FILE pulm-20200930_cal.xml EX-101.CAL 52557
9 XBRL DEFINITION FILE pulm-20200930_def.xml EX-101.DEF 123679
10 XBRL LABEL FILE pulm-20200930_lab.xml EX-101.LAB 281368
11 XBRL PRESENTATION FILE pulm-20200930_pre.xml EX-101.PRE 203856
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 201303877
SIC: 2834 Pharmaceutical Preparations